Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Agnosia × Analgesics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1 Agnosia 1

Interventions

Anesthesia, General 5 Dexmedetomidine 4 Bupivacaine 4 Anesthesia, Local 4 Acupuncture Therapy 4 parecoxib 2 Transcutaneous Electric Nerve Stimulation 2 Saline Solution 2 Ropivacaine 2 Radiofrequency Ablation 2 Pregabalin 2 Morphine 2 Fentanyl 2 Ethanol 2 Dental Occlusion 2 Control Groups 2 Anesthetics, Local 2 Anesthesia, Conduction 2 Analgesics, Opioid 2 loxoprofen 1 engage 8200 1 Yoga 1 Uterine Myomectomy 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Touch 1 Telemedicine 1 Surgical Instruments 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02718404 2022-06-30

HIFU-Bone

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Terminated

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡